BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24249314)

  • 1. Early reduction of therapy-resistant hypertension in a patient after single-sided renal denervation approach.
    Schroeter MR; Koziolek M
    Clin Res Cardiol; 2014 Jan; 103(1):79-81. PubMed ID: 24249314
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: renal sympathetic denervation: a true lack of efficacy, or the victim of a "perfect storm"?
    Baker NC; Waksman R
    Cardiovasc Revasc Med; 2014 Mar; 15(2):61-2. PubMed ID: 24684755
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal denervation in hypertension: simplicity, or complexity?
    Lantelme P; Courand PY; Bricca G
    Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 5. SYMPLICITY: not all that simple.
    Luft FC
    Kidney Int; 2014 May; 85(5):999-1001. PubMed ID: 24786869
    [No Abstract]   [Full Text] [Related]  

  • 6. Now That Renal Denervation Works, How Do We Proceed?
    Papademetriou V; Stavropoulos K; Doumas M; Tsioufis K
    Circ Res; 2019 Mar; 124(5):693-695. PubMed ID: 30817252
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation: a plea for wisdom.
    Lantelme P; Courand PY; Pathak A
    Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current technologies: an introduction.
    Daemen J
    EuroIntervention; 2013 May; 9 Suppl R():R75-82. PubMed ID: 23732160
    [No Abstract]   [Full Text] [Related]  

  • 11. [Renal denervation a new treatment option in resistant arterial hypertension].
    Himmel F; Bode F; Schunkert H; Weil J
    Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?
    Laffin LJ; Bakris GL
    Am J Hypertens; 2017 Sep; 30(9):841-846. PubMed ID: 27838622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.
    Pöss J; Ewen S; Schmieder RE; Muhler S; Vonend O; Ott C; Linz D; Geisel J; Rump LC; Schlaich M; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Aug; 104(8):672-8. PubMed ID: 25715938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response and non-response to renal denervation: who is the ideal candidate?
    Ukena C; Cremers B; Ewen S; Böhm M; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R54-7. PubMed ID: 23732156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenging anatomy, how to treat or not to treat?
    Zeller T; Rastan A; Macharzina R; Noory E
    EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension.
    Gewirtz JR; Bisognano JD
    Cardiol J; 2011; 18(1):97-102. PubMed ID: 21305496
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal denervation: ultima ratio or standard in treatment-resistant hypertension.
    Persu A; Renkin J; Thijs L; Staessen JA
    Hypertension; 2012 Sep; 60(3):596-606. PubMed ID: 22851728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
    Bunte MC; Infante de Oliveira E; Shishehbor MH
    JACC Cardiovasc Interv; 2013 Jan; 6(1):1-9. PubMed ID: 23266234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late renal artery stenosis after percutaneous renal denervation.
    Lambert T; Blessberger H; Grund M; Steinwender C
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e169-e170. PubMed ID: 25090272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.